Literature DB >> 20954882

Antiretroviral-based HIV prevention strategies for women.

Z Mike Chirenje1, Jeanne Marrazzo, Urvi M Parikh.   

Abstract

Almost three decades have elapsed since researchers identified HIV as the cause of AIDS, with current estimates from UNAIDS that 33.4 million adults were living with HIV/AIDS in 2008. Two-thirds of this burden of disease is in Sub-Saharan Africa, and 60% of those infected are women. The disease still remains incurable and current prevention strategies including abstinence, male/female condom use and male circumcision are only partially effective. New strategies to curb the epidemic are urgently needed. Scientists are diligently exploring HIV prevention methods that are safe, effective and affordable. These new biological interventions include oral pre-exposure prophylaxis using oral antiretroviral (ARV) drugs, ARV treatment in HIV-infected persons to reduce transmission and topical ARV-based microbicide formulations.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20954882      PMCID: PMC4381115          DOI: 10.1586/eri.10.79

Source DB:  PubMed          Journal:  Expert Rev Anti Infect Ther        ISSN: 1478-7210            Impact factor:   5.091


  43 in total

Review 1.  Target cells in vaginal HIV transmission.

Authors:  Christopher J Miller; Robin J Shattock
Journal:  Microbes Infect       Date:  2003-01       Impact factor: 2.700

2.  Effectiveness and safety of tenofovir gel, an antiretroviral microbicide, for the prevention of HIV infection in women.

Authors:  Quarraisha Abdool Karim; Salim S Abdool Karim; Janet A Frohlich; Anneke C Grobler; Cheryl Baxter; Leila E Mansoor; Ayesha B M Kharsany; Sengeziwe Sibeko; Koleka P Mlisana; Zaheen Omar; Tanuja N Gengiah; Silvia Maarschalk; Natasha Arulappan; Mukelisiwe Mlotshwa; Lynn Morris; Douglas Taylor
Journal:  Science       Date:  2010-07-19       Impact factor: 47.728

3.  Effectiveness of COL-1492, a nonoxynol-9 vaginal gel, on HIV-1 transmission in female sex workers: a randomised controlled trial.

Authors:  Lut Van Damme; Gita Ramjee; Michel Alary; Bea Vuylsteke; Verapol Chandeying; Helen Rees; Pachara Sirivongrangson; Léonard Mukenge-Tshibaka; Virginie Ettiègne-Traoré; Charn Uaheowitchai; Salim S Abdool Karim; Benoît Mâsse; Jos Perriëns; Marie Laga
Journal:  Lancet       Date:  2002-09-28       Impact factor: 79.321

4.  Nucleoside analogues achieve high concentrations in seminal plasma: relationship between drug concentration and virus burden.

Authors:  A S Pereira; A D Kashuba; S A Fiscus; J E Hall; R R Tidwell; L Troiani; J A Dunn; J J Eron; M S Cohen
Journal:  J Infect Dis       Date:  1999-12       Impact factor: 5.226

Review 5.  Optimal time for initiation of antiretroviral therapy in asymptomatic, HIV-infected, treatment-naive adults.

Authors:  Nandi Siegfried; Olalekan A Uthman; George W Rutherford
Journal:  Cochrane Database Syst Rev       Date:  2010-03-17

Review 6.  Female-controlled methods to prevent sexual transmission of HIV.

Authors:  C J Elias; C Coggins
Journal:  AIDS       Date:  1996-12       Impact factor: 4.177

7.  Efficacy of Carraguard for prevention of HIV infection in women in South Africa: a randomised, double-blind, placebo-controlled trial.

Authors:  Stephanie Skoler-Karpoff; Gita Ramjee; Khatija Ahmed; Lydia Altini; Marlena Gehret Plagianos; Barbara Friedland; Sumen Govender; Alana De Kock; Nazira Cassim; Thesla Palanee; Gregory Dozier; Robin Maguire; Pekka Lahteenmaki
Journal:  Lancet       Date:  2008-12-06       Impact factor: 79.321

8.  Highly active antiretroviral treatment for the prevention of HIV transmission.

Authors:  Reuben Granich; Siobhan Crowley; Marco Vitoria; Ying-Ru Lo; Yves Souteyrand; Christopher Dye; Charlie Gilks; Teguest Guerma; Kevin M De Cock; Brian Williams
Journal:  J Int AIDS Soc       Date:  2010-01-12       Impact factor: 5.396

9.  Some design issues in trials of microbicides for the prevention of HIV infection.

Authors:  Thomas R Fleming; Barbra A Richardson
Journal:  J Infect Dis       Date:  2004-07-20       Impact factor: 5.226

10.  Can highly active antiretroviral therapy reduce the spread of HIV?: A study in a township of South Africa.

Authors:  Bertran Auvert; Sylvia Males; Adrian Puren; Dirk Taljaard; Michel Caraël; Brian Williams
Journal:  J Acquir Immune Defic Syndr       Date:  2004-05-01       Impact factor: 3.731

View more
  3 in total

Review 1.  Biomedical HIV Prevention Including Pre-exposure Prophylaxis and Opiate Agonist Therapy for Women Who Inject Drugs: State of Research and Future Directions.

Authors:  Kimberly Page; Judith Tsui; Lisa Maher; Kachit Choopanya; Suphak Vanichseni; Philip A Mock; Connie Celum; Michael Martin
Journal:  J Acquir Immune Defic Syndr       Date:  2015-06-01       Impact factor: 3.731

2.  Analyses of nanoformulated antiretroviral drug charge, size, shape and content for uptake, drug release and antiviral activities in human monocyte-derived macrophages.

Authors:  Ari S Nowacek; Shantanu Balkundi; JoEllyn McMillan; Upal Roy; Andrea Martinez-Skinner; R Lee Mosley; Georgette Kanmogne; Alexander V Kabanov; Tatiana Bronich; Howard E Gendelman
Journal:  J Control Release       Date:  2010-11-23       Impact factor: 9.776

3.  The effectiveness of tenofovir-based pre-exposure prophylaxis for prevention of HIV acquisition among sub-Saharan African women at high risk: a systematic review.

Authors:  Grant Murewanhema; Moffat Malisheni; Noah Fongwen Takah
Journal:  Pan Afr Med J       Date:  2021-03-26
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.